This was further confirmed by the observation of much more severe bone metastasis in 470 non-small-cell lung cancer (NSCLC) patients with high serum DKK1 levels relative to control groups (Qiao et al., 2017). The gene discussed is DKK1; the disease is non-small cell lung carcinoma.